Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of IperionX Limited due to significant financial losses and a recent correction of financial statements [1][4]. Group 1: Financial Performance - IperionX reported a net loss of approximately $34.8 million for the first half of fiscal year 2026, compared to a loss of $16.2 million in the same period the previous year [3]. - A typographical error in a prior financial statement overstated certain reported figures by approximately $330 million, leading to a decline in the company's share price following the earnings release and subsequent correction [4]. Group 2: Legal Investigation - Johnson Fistel is investigating whether IperionX complied with federal securities laws in light of the financial losses and the correction of the financial statements [1][4]. - Investors who suffered losses from their investment in IperionX stock are encouraged to join the investigation [2].
IperionX Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses